<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Chmielewska JJ</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>Center for Advanced Systems and Engineering, Syracuse University</funding><funding>Narodowe Centrum Nauki</funding><funding>NIMH NIH HHS</funding><funding>National Institutes of Health</funding><funding>Wellcome Trust</funding><pagination>100033</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8439436</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>2(3)</volume><pubmed_abstract>Protein-tyrosine phosphatases (PTPs) are pleomorphic regulators of eukaryotic cellular responses to extracellular signals that function by modulating the phosphotyrosine of specific proteins. A handful of PTPs have been implicated in germline and somatic human disease. Using exome sequencing, we identified missense and truncating variants in &lt;i>PTPN4&lt;/i> in six unrelated individuals with varying degrees of intellectual disability or developmental delay. The variants occurred &lt;i>de novo&lt;/i> in all five subjects in whom segregation analysis was possible. Recurring features include postnatal growth deficiency or excess, seizures, and, less commonly, structural CNS, heart, or skeletal anomalies. &lt;i>PTPN4&lt;/i> is a widely expressed protein tyrosine phosphatase that regulates neuronal cell homeos</pubmed_abstract><journal>HGG advances</journal><pubmed_title>&lt;i>PTPN4&lt;/i> germline variants result in aberrant neurodevelopment and growth.</pubmed_title><pmcid>PMC8439436</pmcid><funding_grant_id>R01MH113106</funding_grant_id><funding_grant_id>R01 MH113106</funding_grant_id><funding_grant_id>2014/14/E/NZ3/00375</funding_grant_id><pubmed_authors>Keren B</pubmed_authors><pubmed_authors>Burkardt D</pubmed_authors><pubmed_authors>Mignot C</pubmed_authors><pubmed_authors>Wynshaw-Boris A</pubmed_authors><pubmed_authors>Chmielewska JJ</pubmed_authors><pubmed_authors>Slaugh R</pubmed_authors><pubmed_authors>Seaver LH</pubmed_authors><pubmed_authors>Granadillo JL</pubmed_authors><pubmed_authors>Adegbola A</pubmed_authors><pubmed_authors>Zuteck M</pubmed_authors><pubmed_authors>Morgan S</pubmed_authors><pubmed_authors>Dziembowska M</pubmed_authors><pubmed_authors>Escobar L</pubmed_authors><pubmed_authors>Turnpenny P</pubmed_authors><pubmed_authors>Rotenberg J</pubmed_authors><pubmed_authors>Ploski R</pubmed_authors></additional><is_claimable>false</is_claimable><name>&lt;i>PTPN4&lt;/i> germline variants result in aberrant neurodevelopment and growth.</name><description>Protein-tyrosine phosphatases (PTPs) are pleomorphic regulators of eukaryotic cellular responses to extracellular signals that function by modulating the phosphotyrosine of specific proteins. A handful of PTPs have been implicated in germline and somatic human disease. Using exome sequencing, we identified missense and truncating variants in &lt;i>PTPN4&lt;/i> in six unrelated individuals with varying degrees of intellectual disability or developmental delay. The variants occurred &lt;i>de novo&lt;/i> in all five subjects in whom segregation analysis was possible. Recurring features include postnatal growth deficiency or excess, seizures, and, less commonly, structural CNS, heart, or skeletal anomalies. &lt;i>PTPN4&lt;/i> is a widely expressed protein tyrosine phosphatase that regulates neuronal cell homeos</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jul</publication><modification>2026-06-12T09:13:12.34Z</modification><creation>2022-02-11T16:14:22.017Z</creation></dates><accession>S-EPMC8439436</accession><cross_references><pubmed>34527963</pubmed><doi>10.1016/j.xhgg.2021.100033</doi></cross_references></HashMap>